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and clinical findings consistent with the disease. The de-
lay in diagnosis led to a life-threatening condition for the 
patient. Physicians in areas where scrub typhus is nonen-
demic should have a high index of suspicion for rickettsial 
infections in patients with recent travel histories to areas 
where the disease is endemic and consider treatment with 
tetracyclines whenever rickettsial infection is suspected. 
Furthermore, the potential for aerosol transmission of O. 
tsutsugamushi from patients with scrub typhus–associated 
ARDS to health care workers should be evaluated.
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To the Editor: Ophthalmomyiasis is a zoonosis gen-
erally caused by Oestrus ovis, a fly that lays eggs on the 
eye of its host. The hatched larvae cause irritation, and left 
untreated, the infestation can lead to blindness (1). The 
disease is rare and is mainly reported as sporadic cases in 
pastoral areas where the population is in close contact with 
common reproductive hosts of the fly, such as sheep and 
goats in the Middle East (2), Southeast Asia (3,4), and the 
Mediterranean Basin (5,6). Only limited ophthalmomyiasis 
outbreaks have been reported around the Mediterranean Sea 
(7). A century ago, the Provence region of southern France 
was a pastoral area, where twice a year, large herds of sheep 
migrated between the pastures in the mountains north of 
the region and the grassland plains in the southwest. These 
migrations were termed transhumance. In 2013, Marseille 
metropolis, the largest urban area in Provence, was chosen 
as the yearly “European Capital of Culture.” In this context, 
from May 17 to June 9, a large-scale transhumance event 
took place, which featured the gathering of huge flocks of 
sheep (Figure) that had passed through many towns in the 
vicinity of Marseille. La transhumance culminated in a pa-
rade through downtown Marseille, where 600 horseback 
riders converged with flocks of 3,000 sheep and goats, and 
>300,000 spectators gathered. 
From the last week of June through the third week 
of July, 4 cases of ophthalmomyiasis were reported in the 
area surrounding Marseille (Figure). Only 1 case had oc-
curred in the region during the previous 5 years. The first 
case-patient was a 45-year-old female teacher, who lived 
and worked in Allauch, located in the immediate suburbs, 
21 km (≈13 mi) east of Marseille. On June 25, while on 
the school playground, she described feeling a fly hit her 
right eye. In the evening, itching and irritation of the eye 
prompted her to seek referral to an ophthalmologic emer-
gency center. Examination concluded the presence of small 
mobile larvae inside the eye, which were identified as O. 
ovis (online Technical Appendix, http://wwwnc.cdc.gov/
EID/article/21/2/14-0974-Techapp1.pdf). 
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The second case-patient was a retired female farmer, 
67 years of age, living near Puyloubier, 49 km (≈30 miles) 
north of Marseille, who reported being stung on the eye by 
an insect during the morning of July 6. In the afternoon, the 
eye became painfully inflamed. On the next day, an oph-
thalmologist performed an excision and extracted O. ovis 
larvae from the eye. 
The third case-patient was a 43-year-old female 
nurse’s aide residing in Meyreuil, which is ≈30 km (≈18 
mi) north of Marseille. On July 13, while she was on her 
terrace, she described ocular trauma by a fly. The next day, 
she sensed a foreign body in her eye, and she consulted an 
ophthalmologist. A simple excision led to the identification 
of an O. ovis larva. 
The final case-patient was a 28-year-old male mason. 
On July 22, while working in Miramas, approximately 63 
km (≈39 miles) he experienced trauma to his left eye. As 
the pain persisted, he consulted an ophthalmology facility 
that same evening. On examination, the presence of an O. 
ovis larva was confirmed, and an ablation was performed. 
All patients recovered without consequences.
O. ovis, also called sheep nasal botfly, is a fly of the 
class Insecta, order Diptera and family Oestridae. It is a 
cosmopolitan parasite that infects the nasal sinuses of 
sheep and goats. During the summer and early autumn, the 
adult female flies are active, laying and retaining eggs until 
they hatch. The fly then ejects many first-instar larvae onto 
the nostril of the host. The O. ovis larvae grow in the mucus 
of the nasal sinus until mature; they are then released from 
the nostrils when the infected host sneezes (8). The larvae 
pupate in the soil for 4–8 weeks, form a chrysalis, in which 
they morph into adults, and then emerge. Occasionally, O. 
ovis can infest humans, which become an intermediate acci-
dental host (7). The 4 cases of ophthalmomyiasis described 
in this report occurred in a restricted area during a 4-week 
period, which corresponds exactly to the time and location 
of la Transhumance, taking into account the 4- to 8-week 
time lag required for the maturation of larvae into adults. 
Three of these cases were directly referred to our laborato-
ry, the regional referent parasitology laboratory. The fourth 
case was reported by an ophthalmology emergency unit. 
Note that ophthalmomyiasis is rare in Marseille; during the 
5 years before la Transhumance of 2013, only a single case 
had been diagnosed in the area.
Overall, this report reminds us that bringing a large 
group of livestock into contact with a dense urban popu-
lation may enhance the risk for transmission of zoonoses. 
The transmitted zoonosis in this case was oestrosis, a benign 
condition that can sometimes progress to blindness if un-
treated. However, other much more severe air-transmitted 
zoonotic diseases associated with sheep and goats, such as Q 
fever, could have been transmitted (9). Without questioning 
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Figure. Map of la Transhumance routes and locations of Oestrus ovis ophthalmomyiasis case-patients in areas surrounding Marseilles, 
France, 2013. Inset shows location of the area in France. A color version of this figure is available online (http://wwwnc.cdc.gov/EID/
article/21/2/14-0974-F1.htm).
the organization of such an event, which the community 
considers to be important from a cultural and economic 
point of view, public health authorities should consider and 
anticipate as much as possible the potential sanitary conse-
quences of such a gathering and prepare medical staff for the 
potential occurrence of unfamiliar diseases.
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To the Editor: Meningococcal disease in US military 
personnel is controlled by vaccines, the first of which was 
developed by the US Army (1–5). In 1985, the quadrivalent 
polysaccharide vaccine (MPSV-4) was implemented as the 
military standard. It was replaced during 2006–2008 by the 
quadrivalent conjugate vaccine (MCV-4). Every person en-
tering US military service is required to receive this vaccine.
Meningococcal disease incidence in active-duty US 
military personnel, historically far above that in the general 
population (6), has decreased >90% since the early 1970s, 
when the first vaccine was introduced (7). Over the last 5 
years, incidences in the military and US general popula-
tions have become equivalent (8). Here we update previ-
ously published data (8) from the Naval Health Research 
Center’s Laboratory-based Meningococcal Disease Sur-
veillance Program of US military personnel. Data-gath-
ering methods and laboratory analyses of samples from 
personnel suspected of having meningococcal disease have 
been previously described (8). Incidences were compared 
by using the New York State Department of Public Health 
Assessment Indicator based on the methods of Breslow and 
Day (9).
During 2006–2013 in US military personnel, only 1 of 
the 28 meningococcal disease cases for which serogroup 
data are available was not serogroups C or B (8 cases each) 
or Y (11 cases). During that period, incidence in US mili-
tary personnel of 0.271 cases per 100,000 person-years did 
not differ significantly (p>0.05) from that of 0.238 in the 
2006–2012 age-matched US general population (persons 
17–64 years of age) (Centers for Disease Control and Pre-
vention [CDC], unpub. data). During 2010–2013, menin-
gococcal disease incidence in military personnel was 0.174 
cases per 100,000 person-years, compared with 0.194 in 
the age-matched 2010–2012 US population. Among mili-
tary personnel, only 1 case each occurred in 2011 (sero-
group Y) and 2012 (serogroup B), and 3 occurred in 2013 
(1 each of serogroups B, C, and Y).
To measure the relative success of the 2 vaccines, 
we compared incidence among military personnel who 
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